pharmaceuticals

The Cigna Group (NYSE: CI), a healthcare company focused on medical insurance and related services, reported results for the first quarter…

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday reported a year-over-year decrease in adjusted profit for the first quarter of 2025,…

Pfizer Inc. (NYSE: PFE) reported its first quarter 2025 earnings results today. Revenues decreased 8% year-over-year to $13.7 billion. GAAP…

Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The…

Bristol Myers Squibb (NYSE: BMY) reported net profit for the first quarter of 2025, compared to a loss last year.…

Merck & Co. Inc. (NYSE: MRK) Thursday reported an increase in adjusted earnings for the first quarter of 2025, while…

Johnson & Johnson (NYSE: JNJ) reported its first quarter 2025 earnings results today. Reported sales increased 2.4% year-over-year to $21.9…

Like many insurance companies, UnitedHealth Group (NYSE: UNH) generally demonstrates the ability to remain relatively resilient during economic downturns, mainly…

For Johnson & Johnson (NYSE: JNJ), investments in its pipeline and exiting lower priority businesses remain central to its strategy…

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) Wednesday reported a narrower net loss for the third quarter of 2025. Revenues…

OS Therapies (NYSE: OSTX) is a cancer immunotherapy company engaged in the development of new treatments for osteosarcoma and other…

Quest Diagnostics Incorporated (NYSE: DGX), a provider of diagnostic information services, has reaffirmed its outlook for fiscal 2025 and provided…

Biotechnology company Illumina, Inc. (NASDAQ: ILMN) has issued fresh earnings guidance for fiscal 2025, to reflect tariff-related challenges to export.…

Baxter International Inc. (NYSE: BAX) on Thursday announced financial results for the fourth quarter of 2024. The medical device maker's…

Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported an increase in revenues and adjusted profit for the third…

Biotechnology company Moderna, Inc. (NASDAQ: MRNA) has reported a net loss for the fourth quarter of 2024, compared to a…

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) reported mixed results for the fourth quarter of 2024, with revenues growing modestly…

Biotechnology company Bristol Myers Squibb (NYSE: BMY) reported lower profit for the fourth quarter of 2024, despite an increase in…

Eli Lilly and Company (NYSE: LLY) Thursday reported a sharp increase in its fourth-quarter revenues. The pharmaceutical company's adjusted earnings…

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the fourth quarter of…

Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2024 earnings results today. Revenues increased 22% year-over-year to $17.8 billion. GAAP…